Evidence map›Paper›PMID 22205736›Full record

ArticleJournal of virology2012

The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1.

Magali Chaumorcel, Marion Lussignol, Lina Mouna, Yolaine Cavignac, Kamau Fahie, Jacqueline Cotte-Laffitte, Adam Geballe, Wolfram Brune, Isabelle Beau, Patrice Codogno and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 168 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. The Autophagy ReceptorViruses · 2024
    Article
  12. Article
  13. Article
  14. Viruses and autophagy: bend, but don't break.Nature reviews. Microbiology · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Antagonism of Protein Kinase R by Large DNA Viruses.Pathogens (Basel, Switzerland) · 2022
    Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Magali ChaumorcelINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Marion Lussignol
Lina Mouna
Yolaine Cavignac
Kamau Fahie
Jacqueline Cotte-Laffitte
Adam Geballe
Wolfram Brune
Isabelle Beau
Patrice Codogno
Audrey Esclatine
Institut Galien Paris-Saclay · FRInserm · FRLeibniz Institute of Virology (LIV) · DEUniversité Paris-Sud · FRUniversity of Washington · US

Funding

TRANSLATIONAL CONTROL OF CYTOMEGALOVIRUS GENE EXPRESSIONR01AI026672 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GEBALLE, ADAM P. · 1994 to 2017
$6.9M
Translational Control of Cytomegalovirus Gene ExpressionR56AI026672 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GEBALLE, ADAM P. · 2018 to 2018
$440k
TRANSLATIONAL CONTROL OF CYTOMEGALOVIRUS GENE EXPRESSIONR29AI026672 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GEBALLE, ADAM P. · 1988 to 1992
–
NIAID NIH HHS AI26672NIAID NIH HHS R01 AI026672NIAID NIH HHS R56 AI026672
6 · The paper itself

Abstract

Human cytomegalovirus modulates macroautophagy in two opposite directions. First, HCMV stimulates autophagy during the early stages of infection, as evident by an increase in the number of autophagosomes and a rise in the autophagic flux. This stimulation occurs independently of de novo viral protein synthesis since UV-inactivated HCMV recapitulates the stimulatory effect on macroautophagy. At later time points of infection, HCMV blocks autophagy (M. Chaumorcel, S. Souquere, G. Pierron, P. Codogno, and A. Esclatine, Autophagy 4:1-8, 2008) by a mechanism that requires de novo viral protein expression. Exploration of the mechanisms used by HCMV to block autophagy unveiled a robust increase of the cellular form of Bcl-2 expression. Although this protein has an anti-autophagy effect via its interaction with Beclin 1, it is not responsible for the inhibition induced by HCMV, probably because of its phosphorylation by c-Jun N-terminal kinase. Here we showed that the HCMV TRS1 protein blocks autophagosome biogenesis and that a TRS1 deletion mutant is defective in autophagy inhibition. TRS1 has previously been shown to neutralize the PKR antiviral effector molecule. Although phosphorylation of eIF2α by PKR has been described as a stimulatory signal to induce autophagy, the PKR-binding domain of TRS1 is dispensable to its inhibitory effect. Our results show that TRS1 interacts with Beclin 1 to inhibit autophagy. We mapped the interaction with Beclin 1 to the N-terminal region of TRS1, and we demonstrated that the Beclin 1-binding domain of TRS1 is essential to inhibit autophagy.

Indexed as

Down-RegulationApoptosis Regulatory ProteinsAutophagyBeclin-1Cell LineCytomegalovirusCytomegalovirus InfectionsHumansMembrane ProteinsProtein BindingViral ProteinsApoptosis Regulatory ProteinsBeclin-1BECN1 protein, humanMembrane ProteinsTRS1 protein, Human herpesvirus 5Viral Proteins

Identifiers

PMID22205736
PMCPMC3302257
OpenAlexW1971204908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.